Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum
Avantor (NYSE: AVTR), a leading global provider of mission-critical products, announced its participation in the KeyBanc Life Sciences and Medtech Investor Forum on March 22, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Avantor (NYSE: AVTR), a leading global provider of mission-critical products, announced its participation in the KeyBanc Life Sciences and Medtech Investor Forum on March 22, 2022. Dr. Ger Brophy, Executive Vice President of Biopharma Production, will discuss the company’s business priorities in a fireside chat at approximately 2:15 p.m. EDT. A live webcast will be available on Avantor's website, with a replay accessible until April 22, 2022.
Details
News Market Reaction – AVTR
The recorded move for AVTR in the trading session of this news was +1.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., March 8, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the KeyBanc Life Sciences and Medtech Investor Forum being held virtually on Tuesday, March 22, 2022. Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor, will discuss the Company's biopharma production business and its priorities in the fireside chat segment beginning at approximately 2:15 p.m. Eastern Daylight Time.
A live webcast can be accessed on the investors section of Avantor's website and a replay will be available through April 22, 2022.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.
Media Contact
Allison Hosak
Senior Vice President, Global Communications and Brand
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Investor Relations Contact
Tommy Thomas
Vice President, Investor Relations
Avantor
781-375-8051
Tommy.Thomas@avantorsciences.com
View original content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-keybanc-life-sciences-and-medtech-investor-forum-301497003.html
SOURCE Avantor and Financial News
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.